Co-Diagnostics, Inc. Capital Expenditures
Co-Diagnostics, Inc. (CODX) reported Capital Expenditures of $160.30 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-13
- Co-Diagnostics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $18.28K, a 95.44% decline year-over-year.
- Co-Diagnostics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $142.02K, a 54.51% increase year-over-year.
- Co-Diagnostics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $131.97K, a 80.81% increase year-over-year.
- Co-Diagnostics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $75.11K, a 56.95% decline year-over-year.
- Co-Diagnostics, Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $700.05K, a 6.45% decline from fiscal 2024.
- Co-Diagnostics, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $748.35K, a 45.19% decline from fiscal 2023.
- Co-Diagnostics, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $1.37M, a 4.36% decline from fiscal 2022.
- Co-Diagnostics, Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $1.43M, a 113.23% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $18.28K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $160.30K 10-Q · filed 2026-08-13 | $292.27K derived: sum of 3 quarters · filed 2026-08-13 | $367.37K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $142.02K 10-Q · filed 2026-05-14 | $273.99K derived: sum of 2 quarters · filed 2026-05-14 | $349.09K derived: sum of 3 quarters · filed 2026-05-14 | $750.15K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $131.97K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $207.07K derived: sum of 2 quarters · filed 2026-03-31 | $608.13K derived: sum of 3 quarters · filed 2026-08-13 | $700.05K 10-K · filed 2026-03-31 |
| 2025-09-30 | $75.11K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $476.17K derived: sum of 2 quarters · filed 2026-08-13 | $568.08K 10-Q · filed 2025-11-13 | $641.07K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $401.06K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $492.97K 10-Q · filed 2026-08-13 | $565.96K derived: sum of 3 quarters · filed 2026-08-13 | $740.40K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $91.91K 10-Q · filed 2026-05-14 | $164.90K derived: sum of 2 quarters · filed 2026-05-14 | $339.34K derived: sum of 3 quarters · filed 2026-05-14 | $437.97K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $72.99K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $247.43K derived: sum of 2 quarters · filed 2026-03-31 | $346.06K derived: sum of 3 quarters · filed 2026-03-31 | $748.35K 10-K · filed 2026-03-31 |
| 2024-09-30 | $174.44K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $273.07K derived: sum of 2 quarters · filed 2025-11-13 | $675.37K 10-Q · filed 2025-11-13 | $1.14M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $98.63K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $500.92K 10-Q · filed 2025-08-14 | $965.52K derived: sum of 3 quarters · filed 2025-08-14 | $1.20M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $402.29K 10-Q · filed 2025-05-08 | $866.89K derived: sum of 2 quarters · filed 2025-05-08 | $1.10M derived: sum of 3 quarters · filed 2025-05-08 | $1.59M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $464.60K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $701.17K derived: sum of 2 quarters · filed 2025-03-27 | $1.19M derived: sum of 3 quarters · filed 2025-03-27 | $1.37M 10-K · filed 2025-03-27 |
| 2023-09-30 | $236.57K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $720.76K derived: sum of 2 quarters · filed 2024-11-07 | $900.70K 10-Q · filed 2024-11-07 | $1.19M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $484.19K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $664.14K 10-Q · filed 2024-08-08 | $957.44K derived: sum of 3 quarters · filed 2024-08-08 | $1.19M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $179.94K 10-Q · filed 2024-05-09 | $473.25K derived: sum of 2 quarters · filed 2024-05-09 | $703.30K derived: sum of 3 quarters · filed 2024-05-09 | $1.21M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $293.30K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $523.35K derived: sum of 2 quarters · filed 2024-03-14 | $1.03M derived: sum of 3 quarters · filed 2024-03-14 | $1.43M 10-K · filed 2024-03-14 |
| 2022-09-30 | $230.05K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $737.61K derived: sum of 2 quarters · filed 2023-11-09 | $1.13M 10-Q · filed 2023-11-09 | $1.26M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $507.56K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $904.16K 10-Q · filed 2023-08-10 | $1.03M derived: sum of 3 quarters · filed 2023-08-10 | $1.19M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $396.60K 10-Q · filed 2023-05-11 | $518.36K derived: sum of 2 quarters · filed 2023-05-11 | $684.08K derived: sum of 3 quarters · filed 2023-05-11 | $926.50K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $121.75K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $287.48K derived: sum of 2 quarters · filed 2023-03-16 | $529.90K derived: sum of 3 quarters · filed 2023-03-16 | $669.46K 10-K · filed 2023-03-16 |
| 2021-09-30 | $165.73K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $408.15K derived: sum of 2 quarters · filed 2022-11-10 | $547.71K 10-Q · filed 2022-11-10 | $1.02M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $242.42K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $381.98K 10-Q · filed 2022-08-11 | $850.70K derived: sum of 3 quarters · filed 2022-08-11 | $951.09K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $139.56K 10-Q · filed 2022-05-12 | $608.27K derived: sum of 2 quarters · filed 2022-05-12 | $708.66K derived: sum of 3 quarters · filed 2022-05-12 | $813.59K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $468.71K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $569.11K derived: sum of 2 quarters · filed 2022-03-24 | $674.03K derived: sum of 3 quarters · filed 2022-03-24 | $774.40K 10-K · filed 2022-03-24 |
| 2020-09-30 | $100.39K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $205.31K derived: sum of 2 quarters · filed 2021-11-12 | $305.68K 10-Q · filed 2021-11-12 | $341.90K derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $104.92K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $205.29K 10-Q · filed 2021-08-12 | $241.51K derived: sum of 3 quarters · filed 2021-08-12 | $265.76K derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $100.37K 10-Q · filed 2021-05-13 | $136.59K derived: sum of 2 quarters · filed 2021-05-13 | $160.84K derived: sum of 3 quarters · filed 2021-05-13 | |
| 2019-12-31 | $36.22K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $60.47K derived: sum of 2 quarters · filed 2021-03-25 | $113.25K 10-K · filed 2021-03-25 | |
| 2019-09-30 | $24.25K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2020-11-16 | $77.03K 10-Q · filed 2020-11-16 | ||
| 2019-06-30 | $52.77K 10-Q/A · filed 2020-11-03 | |||
| 2018-12-31 | $38.84K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $31.65K derived: sum of 2 quarters · filed 2020-03-30 | $31.65K derived: sum of 3 quarters · filed 2020-03-30 | $41.34K 10-K · filed 2020-03-30 |
| 2018-09-30 | -$7.19K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$7.19K derived: sum of 2 quarters · filed 2019-11-12 | $2.50K 10-Q · filed 2019-11-12 | $40.85K derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $1.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $9.69K 10-Q · filed 2019-08-14 | $48.04K derived: sum of 3 quarters · filed 2019-08-14 | $51.39K derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-03-31 | $9.69K 10-Q · filed 2019-05-14 | $48.04K derived: sum of 2 quarters · filed 2019-05-14 | $51.39K derived: sum of 3 quarters · filed 2019-05-14 | $97.95K derived: sum of 4 quarters · filed 2019-05-14 |
| 2017-12-31 | $38.35K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $41.70K derived: sum of 2 quarters · filed 2019-04-01 | $88.26K derived: sum of 3 quarters · filed 2019-04-01 | $129.31K 10-K · filed 2019-04-01 |
| 2017-09-30 | $3.35K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $49.91K derived: sum of 2 quarters · filed 2018-11-14 | $90.96K 10-Q · filed 2018-11-14 | $95.70K derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-06-30 | $46.56K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | $87.61K 10-Q · filed 2018-08-10 | $92.35K derived: sum of 3 quarters · filed 2018-08-10 | $92.35K derived: sum of 4 quarters · filed 2018-08-10 |
| 2017-03-31 | $41.05K 10-Q · filed 2018-05-14 | $45.79K derived: sum of 2 quarters · filed 2018-05-14 | $45.79K derived: sum of 3 quarters · filed 2018-05-14 | |
| 2016-12-31 | $4.74K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-28 | $4.74K derived: sum of 2 quarters · filed 2018-03-28 | $12.24K 10-K · filed 2018-03-28 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $7.50K 10-Q · filed 2017-11-14 | ||
| 2016-06-30 | $7.50K 10-Q · filed 2017-08-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |